​

Alpha Teknova (TKNO) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Alpha Teknova Revenue Highlights

Latest Revenue (Y)

$36.68M

Latest Revenue (Q)

$9.58M

Main Segment (Y)

Lab Essentials

Main Geography (Y)

UNITED STATES

Alpha Teknova Revenue by Period

Alpha Teknova Revenue by Year

DateRevenueChange
2023-12-31$36.68M-11.43%
2022-12-31$41.42M12.27%
2021-12-31$36.89M17.88%
2020-12-31$31.30M55.75%
2019-12-31$20.09M-

Alpha Teknova generated $36.68M in revenue during NA 2023, up -11.43% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Alpha Teknova Revenue by Quarter

DateRevenueChange
2024-09-30$9.58M-0.40%
2024-06-30$9.61M3.49%
2024-03-31$9.29M18.09%
2023-12-31$7.87M-3.70%
2023-09-30$8.17M-29.13%
2023-06-30$11.53M26.38%
2023-03-31$9.12M15.59%
2022-12-31$7.89M-26.20%
2022-09-30$10.69M-8.54%
2022-06-30$11.69M4.87%
2022-03-31$11.15M10.26%
2021-12-31$10.11M7.64%
2021-09-30$9.39M12.98%
2021-06-30$8.31M-8.43%
2021-03-31$9.08M-10.62%
2020-12-31$10.16M13.06%
2020-09-30$8.98M48.64%
2020-06-30$6.04M-1.11%
2020-03-31$6.11M-

Alpha Teknova generated $9.58M in revenue during Q3 2024, up -0.40% compared to the previous quarter, and up 83.07% compared to the same period a year ago.

Alpha Teknova Revenue Breakdown

Alpha Teknova Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Clinical Solutions$6.74M$8.45M$6.79M
Lab Essentials$28.80M$31.77M$27.18M
Other Product$1.15M$1.20M$1.39M
Sample Transport-$6.00K$1.53M

Alpha Teknova's latest annual revenue breakdown by segment (product or service), as of Dec 23: Lab Essentials (78.51%), Clinical Solutions (18.37%), and Other Product (3.12%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Other Product$451.00K$411.00K$306.00K$300.00K$298.00K$293.00K$255.00K$185.00K$303.00K$354.00K$354.00K$432.00K$434.00K$227.00K
Clinical Solutions$1.96M$1.56M$1.72M$879.00K$597.00K$3.65M$1.61M$772.00K$919.00K$2.94M$3.81M$2.44M$1.69M$1.59M
Lab Essentials$7.16M$7.64M$7.27M$6.69M$7.27M$7.58M$7.26M$6.93M$9.47M$8.39M$6.97M$6.74M$7.20M$6.46M
Sample Transport---------$6.00K$495.00K$73.00K$37.00K-

Alpha Teknova's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Lab Essentials (74.78%), Clinical Solutions (20.51%), and Other Product (4.71%).

Alpha Teknova Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
UNITED STATES$35.00M$40.10M-
Non-US$1.68M$1.32M-
U S--$35.81M
Non Us--$1.08M

Alpha Teknova's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (95.41%), and Non-US (4.59%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
UNITED STATES$9.06M$9.23M$8.87M$7.37M$7.83M$11.07M$8.73M$7.61M$10.38M$11.29M$10.82M$9.11M$8.06M-
Non-US$519.00K$386.00K$420.00K$495.00K$342.00K$452.00K$395.00K$277.00K$308.00K$405.00K$327.00K$278.00K--
Non Us-----------$192.00K$252.00K-
U S-----------$9.92M--

Alpha Teknova's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (94.58%), and Non-US (5.42%).

Alpha Teknova Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
PAHCPhibro Animal Health$977.89M$273.16M
COLLCollegium Pharmaceutical$566.77M$159.30M
ANIPANI Pharmaceuticals$486.82M$148.33M
ORGOOrganogenesis$433.14M$115.18M
PROCProcaps Group$409.92M$118.41M
LFCRLifecore Biomedical$128.26M$24.70M
TKNOAlpha Teknova$36.68M$9.58M
RGCRegencell Bioscience--

TKNO Revenue FAQ

What is Alpha Teknova’s yearly revenue?

Alpha Teknova's yearly revenue for 2023 was $36.68M, representing a decrease of -11.43% compared to 2022. The company's yearly revenue for 2022 was $41.42M, representing an increase of 12.27% compared to 2021. TKNO's yearly revenue for 2021 was $36.89M, representing an increase of 17.88% compared to 2020.

What is Alpha Teknova’s quarterly revenue?

Alpha Teknova's quarterly revenue for Q3 2024 was $9.58M, a -0.40% decrease from the previous quarter (Q2 2024), and a 17.22% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $9.61M, a 3.49% increase from the previous quarter (Q1 2024), and a -16.60% decrease year-over-year (Q2 2023). TKNO's quarterly revenue for Q1 2024 was $9.29M, a 18.09% increase from the previous quarter (Q4 2023), and a 1.85% increase year-over-year (Q1 2023).

What is Alpha Teknova’s revenue growth rate?

Alpha Teknova's revenue growth rate for the last 3 years (2021-2023) was -0.57%, and for the last 5 years (2019-2023) was 82.56%.

What are Alpha Teknova’s revenue streams?

Alpha Teknova's revenue streams in c 23 are Clinical Solutions, Lab Essentials, and Other Product. Clinical Solutions generated $6.74M in revenue, accounting 18.37% of the company's total revenue, down -20.21% year-over-year. Lab Essentials generated $28.8M in revenue, accounting 78.51% of the company's total revenue, down -9.35% year-over-year. Other Product generated $1.15M in revenue, accounting 3.12% of the company's total revenue, down -4.26% year-over-year.

What is Alpha Teknova’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Alpha Teknova was Lab Essentials. This segment made a revenue of $28.8M, representing 78.51% of the company's total revenue.